Researchers have identified four "red flag" signs and symptoms associated with an increased risk of early-onset colorectal cancer and suggest prompt diagnostic workup when present.
"Clinicians treating IBD patients should take the time to response into consideration because it leads to rapid improvement in quality of life and reduced need for steroids," said Atsushi Sakurabam, MD,
The drug was statistically superior to the placebo across all key endpoints in phase 2b study, regardless of patient response or intolerance to conventional and advanced therapies.